AIMT

Aimmune Therapeutics
AIMT

Delisted

AIMT was delisted on the 12th of October, 2020.

155 hedge funds and large institutions have $1.57B invested in Aimmune Therapeutics in 2019 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
155
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$16.3M
Puts
$8.33M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
126
$96K
127
$87K
128
$87K
129
$84K
130
$82K
131
$78K
132
$73K
133
$53K
134
$33.5K
135
$33K
136
$33K
137
$27K
138
$14K
139
$14K
140
$12K
141
$11K
142
$9.94K
143
$8K
144
$7K
145
$5K
146
$3K
147
$3K
148
$3K
149
$2K
150
$1K